Taseera Kabanda
Overview
Explore the profile of Taseera Kabanda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
136
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Atwine R, Yekosani M, Birungi A, Ssenkumba B, Tuhamize B, Ezinga R, et al.
PLoS One
. 2025 Jan;
20(1):e0317222.
PMID: 39869644
Background: Antiretroviral therapy (ART) restores cellular immunity, significantly reducing AIDS-related mortality and morbidity thus improving the quality of life among People living with HIV (PLHIV). Studies done in several countries...
2.
Ahabwe O, Kabanda T, Abesiga L, Mugisha J, Kayondo M, Ngonzi J, et al.
BMC Womens Health
. 2023 Nov;
23(1):572.
PMID: 37932705
Background: Abnormal vaginal discharge is a common complaint among women of reproductive age, affecting about one- third of all women. In resource-limited settings where access to laboratory services is limited,...
3.
Zamarano H, Musinguzi B, Kabajulizi I, Manirakiza G, Guti W, Muhwezi I, et al.
BMC Microbiol
. 2021 Nov;
21(1):303.
PMID: 34736415
Introduction: Neonatal septicaemia is one of the most common leading causes of neonatal morbidity and mortality in developing countries. It is estimated to affect more than 30 million people worldwide...
4.
Njovu I, Musinguzi B, Mwesigye J, Kassaza K, Turigurwa J, Nuwagira E, et al.
Ther Adv Infect Dis
. 2021 Sep;
8:20499361211042477.
PMID: 34484738
Background: Pulmonary mycoses are important diseases of the respiratory tract caused by pulmonary fungal pathogens. These pathogens are responsible for significant morbidity and mortality rates worldwide; however, less attention has...
5.
Ankunda R, Nambile Cumber S, Atuhaire C, Kabanda T, Nkfusai C, Wirsiy F, et al.
BMC Infect Dis
. 2020 Mar;
20(1):235.
PMID: 32192458
Background: Loss to follow-up (LTFU) deprives HIV-exposed infants the lifesaving care required and results in exposing HIV free infants to virus requisition risk. We aimed to determine the rate of...
6.
Kabanda T, Siedner M, Klausner J, Muzoora C, Boulware D
Clin Infect Dis
. 2013 Sep;
58(1):113-6.
PMID: 24065327
The cryptococcal antigen (CRAG) lateral flow assay (LFA) had 100% sensitivity and specificity on cerebrospinal fluid samples. Pretreatment LFA titers correlated with quantitative cultures (R(2) = 0.7) and predicted 2-...
7.
Muzoora C, Kabanda T, Ortu G, Ssentamu J, Hearn P, Mwesigye J, et al.
J Infect
. 2011 Nov;
64(1):76-81.
PMID: 22079502
Objective: To define more rapidly effective initial antifungal regimens sustainable in resource-constrained settings. Methods: Cohort study in SW Uganda: Thirty HIV-seropositive, antiretroviral therapy-naïve, patients with first episode cryptococcal meningitis were...